FDA Permits Marketing of Xpert MTB/RIF Assay

The Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.

http://www.infectioncontroltoday.com/news/2013/07/fda-permits-marketing-of-xpert-mtb-rif-assay.aspx?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+News-ICT+%28ICT_News%29